Live Breaking News & Updates on University Hospital Of Leipzig

Stay updated with breaking news from University hospital of leipzig. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Researchers | Walk 7,500 steps a day to lower risk of developing post-operative complications: Study

Research links long-term physical activity to better outcomes ....

Carson Gehl , Erasmus Medical Centre , American College Of Surgeons , College Of Wisconsin , University Hospital Of Leipzig , Medical College , American College , University Hospital , United States ,

Data for Luspatercept Highlight Evolving Treatment Landscape in Lower-Risk MDS

Uwe Platzbecker, MD, discusses the FDA approval of luspatercept for the treatment of anemia in patients who have not had prior treatment with erythropoiesis-stimulating agent and may require regular red blood cell transfusions could change the sequencing of agents for this patient population. ....

United States , Uwe Platzbecker , European Union , European Hematology Association , Bristol Myers Squibb , University Hospital Of Leipzig , Molecular International Prognostic Scoring System , European Medicines Agency , Society Of Hematologic Oncology Annual Meeting , American Society Of Clinical Oncology Annual Meeting , University Hospital , Clinical Oncology Annual , North America , Hematologic Oncology Annual Meeting , International Prognostic Scoring System , Della Porta , Society Of Hematologic Oncology Annual Meeting Soho , Myeloproliferative Neoplasms ,

Geron Presentations at Upcoming EHA Annual Meeting to Report Updated Durability, Disease Modification and Favorable Patient Reported Outcomes (PRO) in Imetelstat-Treated Lower Risk MDS Patients in IMerge Phase 3

Longer follow-up data for 1-year transfusion independence in IMerge Phase 3, which demonstrated statistically significant and clinically meaningful continuous, durable efficacy

Strong. | May 11, 2023 ....

France General , United States , Faye Feller , Nicolas Chatain , Mikkael Sekeres , Nicolas Chapuis , Valeria Santini , Uwe Platzbecker , University Hospital Of Leipzig , Drug Administration , Sylvester Comprehensive Cancer Center , University Hospital Aachen , European Hematology Association , Geron Corporation Nasdaq , International Working Group , University Of Miami Health System , University Of Florence School Medicine , Geron Corporation , Annual Meeting , Executive Vice President , Chief Medical Officer , Lower Risk Myelodysplastic Syndromes , Transfusion Independence , Heavily Transfused Non Del , Erythropoiesis Stimulating Agents , University Hospital ,

Geron Corporation: Geron Presentations at Upcoming EHA Annual Meeting to Report Updated Durability, Disease Modification and Favorable Patient Reported Outcomes (PRO) in Imetelstat-Treated Lower Risk MDS Patients in IMerge Phase 3

Longer follow-up data for 1-year transfusion independence (TI) in IMerge Phase 3, which demonstrated statistically significant and clinically meaningful continuous, durable efficacy Strong ....

France General , United States , Nicolas Chatain , Faye Feller , Uwe Platzbecker , Valeria Santini , Kaplan Meier , Aaron Feingold , Mikkael Sekeres , Nicolas Chapuis , Geron Corporation Nasdaq , International Working Group , European Hematology Association , University Hospital Aachen , University Hospital Of Leipzig , Sylvester Comprehensive Cancer Center , Exchange Commission , Drug Administration , University Of Florence School Medicine , University Of Miami Health System , Eastern Time , Annual Meeting , Executive Vice President , Chief Medical Officer , Data Lower Risk Myelodysplastic Syndromes , Transfusion Independence ,

Non-Pharmaceutical Interventions Affected Characteristics, Seasonality of RSV

Further epidemiologic studies on nonpharmaceutical interventions are warranted to assess their relationship with respiratory syncytial virus (RSV). ....

University Hospital Of Leipzig , University Hospital ,